The SA Greenberg Lab: The Inclusion Body Myositis Research Project

IBM and Myositis Research

We are a research group dedicated to understanding and finding treatment for sporadic inclusion body myositis (s-IBM), dermatomyositis, polymyositis, and other inflammatory myopathies. We are affiliated with Brigham and Women's Hospital, Department of Neurology, Division of Neuromuscular Disease, Harvard Medical School; the Children's Hospital Informatics Program; and the Harvard-MIT Division of Health Sciences and Technology.

You can learn more here about our specific efforts for inclusion body myositis.

This web site contains extensive information about these diseases, data generated in our studies, and descriptions of our research projects. If this work interests you, please feel free to contact us or contribute to our efforts.

Last updated: 09/17/2009

Inclusion Body Myositis

Inclusion body myositis (IBM) is a disease causing progressive muscle weakness and atrophy for which no reliable effective treatment currently exists. Learn more.

News and Announcements

September 17, 2009: Read this paper published in the British Medical Journal How citation distortions create unfounded authority.

See also the extensive supplementary data for this article, the BMJ link which includes rapid responses, and a BMJ editorial.

  • Hms
  • Bwh
  • Chb
  • Chip
  • Hst
© 2009 The Greenberg Lab. Data Release Policy
About Us | Research | Publications | Data | Resources